Skip to main content
S&P 5007,650.50+0.17%DOW51,682.64-0.18%NASDAQ26,522.54+0.39%BTC$81,273.00+6.27%ETH$2,618.91+7.14%GOLD$4,415.90+0.37%OIL$95.47-1.81%
Smart Investors Daily
Medtronic plc logo

NASDAQ · MDT

Medtronic plc

Healthcare · Medical - Devices

$92.13

Down-$0.64 (-0.69%)

Updated Sep 20, 2026, 11:46 AM

SID Score

6.6/10

Composite research score

Smart Money

46/100

Neutral

Market cap
127.94B
P/E ratio
26.83
Dividend yield
3.83%
52-week range
$73.31 – $105.50
Volume
15.45M
Avg. volume
7.16M

Price performance

MDT price history

1M range · 19 trading sessions · Daily adjusted prices

MDT closed at $92.13 after 19 trading sessions, down 0.83% for the selected period.

Last close
$92.13
Period change
-0.83%
Period low
$89.97
Period high
$94.17
Daily close
View OHLC price history
MDT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 18, 2026$92.28$93.03$92.04$92.1315.45M
Sep 17, 2026$92.63$93.43$92.21$92.7710.9M
Sep 16, 2026$93.44$94.545$92.42$92.6010.49M
Sep 15, 2026$93.69$94.70$92.73$93.757.15M
Sep 14, 2026$93.35$94.075$92.73$93.809.26M
Sep 11, 2026$93.00$93.00$90.26$90.965.41M
Sep 10, 2026$92.00$92.535$90.58$91.625.12M
Sep 9, 2026$92.39$93.39$91.75$91.897.73M
Sep 8, 2026$93.25$93.30$91.42$92.398.2M
Sep 4, 2026$92.76$94.74$92.31$94.179.01M
Sep 3, 2026$93.04$93.72$90.965$93.107.41M
Sep 2, 2026$92.25$94.605$91.47$92.189.16M
Sep 1, 2026$94.00$95.41$90.80$92.0418.84M
Aug 31, 2026$90.75$91.12$90.04$90.6512.63M
Aug 28, 2026$90.29$91.56$89.94$91.236.47M
Aug 27, 2026$91.50$91.61$89.96$89.977.77M
Aug 26, 2026$91.08$92.53$90.75$92.026.05M
Aug 25, 2026$92.275$92.82$91.11$91.146.8M
Aug 24, 2026$93.43$94.05$92.655$92.906.01M

Latest MDT news

The latest Smart Investors Daily articles mentioning MDT.

Stock researchCompany · Overview

MDT research

Overview

Company profile and research snapshot.

Company profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$111.50
Implied upside
—
Analysts
22
MDT recent ratings
DateFirmRatingTarget
Sep 3, 2026UBSBuy—
Sep 2, 2026Truist SecuritiesHold—
Sep 2, 2026Wells FargoOverweight—
Sep 2, 2026RBC CapitalOutperform—
Sep 2, 2026B of A SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 19, 2026

What Does Medtronic (MDT) FDA Clearance Mean For Its Hugo Surgery Push?

Medtronic (NYSE:MDT) received FDA clearance for its LigaSure vessel-sealing device on the Hugo robotic surgery system in the U.S. The authorization allows LigaSure to be used on the Hugo platform for soft-tissue procedures in U.S. hospitals and surgical centers. The cleared configuration integrates a widely used vessel-sealing tool with Medtronic’s robotic-assisted surgery platform for general surgery use. The new FDA clearance for LigaSure on Hugo is one more factor to weigh alongside the...

Yahoo · Sep 18, 2026

Medical Devices Market Size to Hit $817.78 Billion by 2031 – MarketsandMarkets™

Delray Beach, FL, Sept. 18, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global medical devices market size will grow from USD 580.79 billion in 2026 to USD 817.78 billion by 2031, at a CAGR of 7.1% during the forecast period. Market growth is fueled by the rising prevalence of chronic diseases, an expanding aging population, increasing demand for minimally invasive procedures, continuous technological advancements in AI-enabled, robotic, and connected medical devices, expanding heal

Yahoo · Sep 17, 2026

Medtronic (MDT) Raises its Outlook Again as Heart Device Demand Keeps Climbing

Reuters reported that Medtronic plc (NYSE:MDT) raised the lower end of its fiscal 2027 profit forecast and its revenue growth outlook on September 1, banking on strong demand for heart devices used in complex cardiovascular procedures. The Ireland-based company raised the lower end of its adjusted per-share profit forecast to $5.94 from $5.90, keeping the […]

Yahoo · Sep 11, 2026

MiniMed’s (MMED) New Pump Lineup Is Finally Winning Patients Over

On September 1, MiniMed (NASDAQ:MMED) reported its first full quarter as a stand-alone public company, and the numbers suggest the split from Medtronic is already paying off. Revenue jumped 15.8% to $843 million, and management raised its full-year growth outlook just months after the IPO roadshow. The catalyst is simple. A new pump finally shipped, […]

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By